Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in Eur J Cancer

Retrieve available abstracts of 31 articles:
HTML format
Text format

Single Articles

    June 2017
  1. HONG N, Yoon HG, Seo DH, Park S, et al
    Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
    Eur J Cancer. 2017;82:103-114.
    PubMed     Text format     Abstract available

    May 2017
  2. MARLOW LAV, Chorley AJ, Haddrell J, Ferrer R, et al
    Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women.
    Eur J Cancer. 2017;80:30-38.
    PubMed     Text format     Abstract available

  3. RUSCITO I, Cacsire Castillo-Tong D, Vergote I, Ignat I, et al
    Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTI
    Eur J Cancer. 2017;79:214-225.
    PubMed     Text format     Abstract available

    April 2017
  4. SALEHI S, Avall-Lundqvist E, Legerstam B, Carlson JW, et al
    Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial.
    Eur J Cancer. 2017;79:81-89.
    PubMed     Text format     Abstract available

  5. JOLY F, Hilpert F, Okamoto A, Stuart G, et al
    Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer.
    Eur J Cancer. 2017;78:133-138.
    PubMed     Text format     Abstract available

  6. EGGINK FA, Mom CH, Bouwman K, Boll D, et al
    Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.
    Eur J Cancer. 2017;78:82-90.
    PubMed     Text format     Abstract available

    March 2017
  7. GEORGE A, Kristeleit R, Rafii S, Michie CO, et al
    Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials.
    Eur J Cancer. 2017;76:52-59.
    PubMed     Text format     Abstract available

  8. LYNGE E, Lonnberg S, Tornberg S
    Cervical cancer incidence in elderly women-biology or screening history?
    Eur J Cancer. 2017;74:82-88.
    PubMed     Text format     Abstract available

    February 2017
  9. AMBATIPUDI S, Horvath S, Perrier F, Cuenin C, et al
    DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.
    Eur J Cancer. 2017;75:299-307.
    PubMed     Text format     Abstract available

    December 2016
  10. DE JONGE MM, Mooyaart AL, Vreeswijk MP, de Kroon CD, et al
    Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report.
    Eur J Cancer. 2016;72:215-225.
    PubMed     Text format     Abstract available

  11. LAMBERTINI M, Cinquini M, Moschetti I, Peccatori FA, et al
    Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
    Eur J Cancer. 2016;71:25-33.
    PubMed     Text format     Abstract available

    November 2016
  12. ROUZIER R, Gouy S, Selle F, Lambaudie E, et al
    Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.
    Eur J Cancer. 2016;70:133-142.
    PubMed     Text format     Abstract available

  13. MARTH C, Vergote I, Scambia G, Oberaigner W, et al
    ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
    Eur J Cancer. 2016;70:111-121.
    PubMed     Text format     Abstract available

  14. VERGOTE I, Banerjee S, Gerdes AM, van Asperen C, et al
    Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.
    Eur J Cancer. 2016;69:127-134.
    PubMed     Text format     Abstract available

  15. JEPPESEN MM, Jensen PT, Gilsa Hansen D, Iachina M, et al
    The nature of early-stage endometrial cancer recurrence-A national cohort study.
    Eur J Cancer. 2016;69:51-60.
    PubMed     Text format     Abstract available

    September 2016
  16. ABDEL-QADIR H, Amir E, Fischer HD, Fu L, et al
    The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer.
    Eur J Cancer. 2016;68:11-21.
    PubMed     Text format     Abstract available

  17. HUANG KC, Yang J, Ng MC, Ng SK, et al
    Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells.
    Eur J Cancer. 2016;67:152-163.
    PubMed     Text format     Abstract available

    August 2016
  18. NAGRANI R, Mhatre S, Rajaraman P, Soerjomataram I, et al
    Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity.
    Eur J Cancer. 2016;66:153-161.
    PubMed     Text format     Abstract available

  19. KLAR M, Hasenburg A, Hasanov M, Hilpert F, et al
    Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
    Eur J Cancer. 2016;66:114-124.
    PubMed     Text format     Abstract available

  20. KLEPPE M, van der Aa MA, Van Gorp T, Slangen BF, et al
    The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer.
    Eur J Cancer. 2016;66:83-90.
    PubMed     Text format     Abstract available

  21. KOSKAS M, Jozwiak M, Fournier M, Vergote I, et al
    Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.
    Eur J Cancer. 2016;65:185-191.
    PubMed     Text format     Abstract available

  22. VAN DER STEEN-BANASIK E, Christiaens M, Shash E, Coens C, et al
    Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma.
    Eur J Cancer. 2016;65:172-181.
    PubMed     Text format     Abstract available

    July 2016
  23. DU BOIS A, Ewald-Riegler N, de Gregorio N, Reuss A, et al
    Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynakologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914].
    Eur J Cancer. 2016 Jul 25. pii: S0959-8049(16)32278.
    PubMed     Text format    

  24. LEMETRE C, Vieites B, Ng CK, Piscuoglio S, et al
    RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.
    Eur J Cancer. 2016;64:149-158.
    PubMed     Text format     Abstract available

    June 2016
  25. ONDA T, Satoh T, Saito T, Kasamatsu T, et al
    Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncolog
    Eur J Cancer. 2016;64:22-31.
    PubMed     Text format     Abstract available

  26. PALMA-ARDILES G, Hernandez-Fernandez W, Gianuzzi X, Hernandez AV, et al
    Letter to the Editor regarding the paper by Sang-Hee Yoon et al., Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis.
    Eur J Cancer. 2016 Jun 15. pii: S0959-8049(16)32166.
    PubMed     Text format    

    May 2016
  27. ARTS-DE JONG M, de Bock GH, van Asperen CJ, Mourits MJ, et al
    Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
    Eur J Cancer. 2016;61:137-145.
    PubMed     Text format     Abstract available

  28. KOSKAS M, Fournier M, Vanderstraeten A, Walker F, et al
    Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study.
    Eur J Cancer. 2016;61:52-60.
    PubMed     Text format     Abstract available

  29. PAOLINI F, Curzio G, Melucci E, Terrenato I, et al
    Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions.
    Eur J Cancer. 2016;58:52-61.
    PubMed     Text format     Abstract available

    April 2016
  30. AMMOTHUMKANDY A, Maliekal TT, Bose MV, Rajkumar T, et al
    CD66 and CD49f expressing cells are associated with distinct neoplastic phenotypes and progression in human cervical cancer.
    Eur J Cancer. 2016;60:166-178.
    PubMed     Text format     Abstract available

    March 2016
  31. PANT S, Jones SF, Kurkjian CD, Infante JR, et al
    A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer.
    Eur J Cancer. 2016;56:1-9.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.